Cargando…
The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
The Lysosomal sequestration of weak-base anticancer drugs is one putative mechanism for resistance to chemotherapy but it has never been directly proven. We addressed the question of whether the lysosomal sequestration of tyrosine kinase inhibitors (TKIs) itself contributes to the drug resistance in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921012/ https://www.ncbi.nlm.nih.gov/pubmed/31683643 http://dx.doi.org/10.3390/biom9110675 |
_version_ | 1783481065724182528 |
---|---|
author | Ruzickova, Eliska Skoupa, Nikola Dolezel, Petr Smith, Dennis A. Mlejnek, Petr |
author_facet | Ruzickova, Eliska Skoupa, Nikola Dolezel, Petr Smith, Dennis A. Mlejnek, Petr |
author_sort | Ruzickova, Eliska |
collection | PubMed |
description | The Lysosomal sequestration of weak-base anticancer drugs is one putative mechanism for resistance to chemotherapy but it has never been directly proven. We addressed the question of whether the lysosomal sequestration of tyrosine kinase inhibitors (TKIs) itself contributes to the drug resistance in vitro. Our analysis indicates that lysosomal sequestration of an anticancer drug can significantly reduce the concentration at target sites, only when it simultaneously decreases its extracellular concentration due to equilibrium, since uncharged forms of weak-base drugs freely diffuse across cellular membranes. Even though the studied TKIs, including imatinib, nilotinib, and dasatinib, were extensively accumulated in the lysosomes of cancer cells, their sequestration was insufficient to substantially reduce the extracellular drug concentration. Lysosomal accumulation of TKIs also failed to affect the Bcr-Abl signaling. Cell pre-treatment with sunitinib significantly enhanced the lysosomal accumulation of the TKIs used; however, without apparent lysosomal biogenesis. Importantly, even increased lysosomal sequestration of TKIs neither decreased their extracellular concentrations nor affected the sensitivity of Bcr-Abl to TKIs. In conclusion, our results clearly show that the lysosomal sequestration of TKIs failed to change their concentrations at target sites, and thus, can hardly contribute to drug resistance in vitro. |
format | Online Article Text |
id | pubmed-6921012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69210122019-12-24 The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance Ruzickova, Eliska Skoupa, Nikola Dolezel, Petr Smith, Dennis A. Mlejnek, Petr Biomolecules Article The Lysosomal sequestration of weak-base anticancer drugs is one putative mechanism for resistance to chemotherapy but it has never been directly proven. We addressed the question of whether the lysosomal sequestration of tyrosine kinase inhibitors (TKIs) itself contributes to the drug resistance in vitro. Our analysis indicates that lysosomal sequestration of an anticancer drug can significantly reduce the concentration at target sites, only when it simultaneously decreases its extracellular concentration due to equilibrium, since uncharged forms of weak-base drugs freely diffuse across cellular membranes. Even though the studied TKIs, including imatinib, nilotinib, and dasatinib, were extensively accumulated in the lysosomes of cancer cells, their sequestration was insufficient to substantially reduce the extracellular drug concentration. Lysosomal accumulation of TKIs also failed to affect the Bcr-Abl signaling. Cell pre-treatment with sunitinib significantly enhanced the lysosomal accumulation of the TKIs used; however, without apparent lysosomal biogenesis. Importantly, even increased lysosomal sequestration of TKIs neither decreased their extracellular concentrations nor affected the sensitivity of Bcr-Abl to TKIs. In conclusion, our results clearly show that the lysosomal sequestration of TKIs failed to change their concentrations at target sites, and thus, can hardly contribute to drug resistance in vitro. MDPI 2019-10-31 /pmc/articles/PMC6921012/ /pubmed/31683643 http://dx.doi.org/10.3390/biom9110675 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ruzickova, Eliska Skoupa, Nikola Dolezel, Petr Smith, Dennis A. Mlejnek, Petr The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance |
title | The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance |
title_full | The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance |
title_fullStr | The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance |
title_full_unstemmed | The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance |
title_short | The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance |
title_sort | lysosomal sequestration of tyrosine kinase inhibitors and drug resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921012/ https://www.ncbi.nlm.nih.gov/pubmed/31683643 http://dx.doi.org/10.3390/biom9110675 |
work_keys_str_mv | AT ruzickovaeliska thelysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT skoupanikola thelysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT dolezelpetr thelysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT smithdennisa thelysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT mlejnekpetr thelysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT ruzickovaeliska lysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT skoupanikola lysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT dolezelpetr lysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT smithdennisa lysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance AT mlejnekpetr lysosomalsequestrationoftyrosinekinaseinhibitorsanddrugresistance |